# TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

> **NCT02492477** · PHASE1 · TERMINATED · sponsor: **Krankenhaus Barmherzige Schwestern Linz** · enrollment: 4 (actual)

## Conditions studied

- Adjuvant Chemotherapy
- Solid Tumours
- Port-A-Cath

## Interventions

- **PROCEDURE:** evaluation of PORT-A-CATH®
- **DRUG:** blocking with Medunasal®-Heparinblock
- **DRUG:** restoration of PORT-A-CATH® with Alteplase

## Key facts

- **NCT ID:** NCT02492477
- **Lead sponsor:** Krankenhaus Barmherzige Schwestern Linz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2018-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492477, "TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02492477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*